日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity

PAI-1 是一种潜在的转录沉默剂,可支持膀胱癌细胞活性

Hideki Furuya, Yuka Sasaki, Runpu Chen, Rafael Peres, Kanani Hokutan, Kaoru Murakami, Nari Kim, Owen T M Chan, Ian Pagano, Lars Dyrskjøt, Jørgen B Jensen, Per-Uno Malmstrom, Ulrika Segersten, Yijun Sun, Abolfazl Arab, Hani Goodarzi, Steve Goodison, Charles J Rosser

Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth

抗 CXCL1 单克隆抗体 (HL2401) 作为抑制 IL6 表达和肿瘤生长的新型药物

Makito Miyake, Hideki Furuya, Sayuri Onishi, Kanani Hokutan, Satoshi Anai, Owen Chan, Sixiang Shi, Kiyohide Fujimoto, Steve Goodison, Weibo Cai, Charles J Rosser

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort

用于检测膀胱癌的多重尿液免疫测定:日本队列分析

Steve Goodison, Osamu Ogawa, Yoshiyuki Matsui, Takashi Kobayashi, Makito Miyake, Sayuri Ohnishi, Kiyohide Fujimoto, Yunfeng Dai, Yoshiko Shimizu, Kazue Tsukikawa, Hideki Furuya, Charles J Rosser

A multiplex immunoassay for the non-invasive detection of bladder cancer

用于无创检测膀胱癌的多重免疫测定

Yoshiko Shimizu, Hideki Furuya, Peter Bryant Greenwood, Owen Chan, Yunfeng Dai, Mark D Thornquist, Steve Goodison, Charles J Rosser

PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation

PAI-1 通过上调细胞周期蛋白 D3/cdk4/6 导致细胞周期进入 G1 期

Evan Gomes Giacoia, Makito Miyake, Adrienne Lawton, Steve Goodison, Charles J Rosser

Urinary protein biomarker panel for the detection of recurrent bladder cancer

用于检测复发性膀胱癌的尿蛋白生物标志物组

Charles J Rosser, Myron Chang, Yunfeng Dai, Shanti Ross, Lourdes Mengual, Antonio Alcaraz, Steve Goodison

Simultaneous multi-analyte urinary protein assay for bladder cancer detection

同时进行多分析物尿蛋白测定以检测膀胱癌

Charles J Rosser, Yunfeng Dai, Makito Miyake, Ge Zhang, Steve Goodison

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer

膀胱癌中 syndecan-1 表达从细胞膜转移到细胞质的临床意义

Makito Miyake, Adrienne Lawton, Yunfeng Dai, Myron Chang, Lourdes Mengual, Antonio Alcaraz, Steve Goodison, Charles J Rosser

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature

尿液膀胱癌生物标志物特征的验证和临床病理学关联

Ge Zhang, Evan Gomes-Giacoia, Yunfeng Dai, Adrienne Lawton, Makito Miyake, Hideki Furuya, Steve Goodison, Charles J Rosser

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions

促红细胞生成素是一种JAK2和ERK1/2效应物,可在缺氧条件下促进肾肿瘤细胞增殖

Makito Miyake, Steve Goodison, Adrienne Lawton, Ge Zhang, Evan Gomes-Giacoia, Charles J Rosser